Cart
sales@molnova.com
TAK-100
CAS No. 907609-33-0
TAK-100( TAK100 )
Catalog No. M16521 CAS No. 907609-33-0
TAK-100 is a potent, selective and orally active inhibitor of DPP-4 with IC50 of 5.3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTAK-100
-
NoteResearch use only, not for human use.
-
Brief DescriptionTAK-100 is a potent, selective and orally active inhibitor of DPP-4 with IC50 of 5.3 nM.
-
DescriptionTAK-100 is a potent, selective and orally active inhibitor of DPP-4 with IC50 of 5.3 nM, shows no inhibition on DPP2/8/9.Diabetes Phase 1 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsTAK100
-
PathwayMetabolic Enzyme/Protease
-
TargetDPP
-
RecptorDPP
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number907609-33-0
-
Formula Weight354.494
-
Molecular FormulaC22H30N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name[5-(aminomethyl)-6-(2,2-dimethylpropyl)-2-ethyl4-(4-methylphenyl)pyridin-3-yl]acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Miyamoto Y, et al. J Med Chem. 2011 Feb 10;54(3):831-50.
molnova catalog
related products
-
Gemigliptin
A novel potent, selective, competitive and orally active DPP4 inhibitor with potential for the treatment of type 2 diabetes.
-
Saxagliptin
A highly potent, long-acting, orally active DPP4 inhibitor with Ki of 0.6 nM.
-
P32/98 hemifumarate
P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the Zucker diabetic rat model, and may be useful in studies of type 2 diabetes and colitis.
